HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 44, 45990-45997, October 29, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/44/45990    most recent M406146200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Botzki, A. Articles by Buschauer, A. Search for Related Content PubMed PubMed Citation Articles by Botzki, A. Articles by Buschauer, A. Social Bookmarking                      What's this?

L-Ascorbic Acid 6-Hexadecanoate, a Potent Hyaluronidase Inhibitor

X-RAY STRUCTURE AND MOLECULAR MODELING OF ENZYME-INHIBITOR COMPLEXES^*

Alexander Botzki, Daniel J. Rigden, Stephan Braun, Masatoshi Nukui¶, Sunnhild Salmen, Julia Hoechstetter, Günther Bernhardt, Stefan Dove, Mark J. Jedrzejas¶||, and Armin Buschauer**

From the Institute of Pharmacy, University of Regensburg, Universitätsstrasse 31, 93040 Regensburg, Germany, the School of Biological Sciences, University of Liverpool, Crown St., Liverpool L69 7ZB, United Kingdom, and the ^¶Children's Hospital Oakland Research Institute, Oakland, California 94609

Hyaluronidases are enzymes that degrade hyaluronan, an important component of the extracellular matrix. The mammalian hyaluronidases are considered to be involved in many (patho)physiological processes like fertilization, tumor growth, and metastasis. Bacterial hyaluronidases, also termed hyaluronate lyases, contribute to the spreading of microorganisms in tissues. Such roles for hyaluronidases suggest that inhibitors could be useful pharmacological tools. Potent and selective inhibitors are not known to date, although L-ascorbic acid has been reported to be a weak inhibitor of Streptococcus pneumoniae hyaluronate lyase (SpnHL). The x-ray structure of SpnHL complexed with L-ascorbic acid has been elucidated suggesting that additional hydrophobic interactions might increase inhibitory activity. Here we show that L-ascorbic acid 6-hexadecanoate (Vcpal) is a potent inhibitor of both streptococcal and bovine testicular hyaluronidase (BTH). Vcpal showed strong inhibition of Streptococcus agalactiae hyaluronate lyase with an IC₅₀ of 4 µM and weaker inhibition of SpnHL and BTH with IC₅₀ values of 100 and 56 µM, respectively. To date, Vcpal has proved to be one of the most potent inhibitors of hyaluronidase. We also determined the x-ray structure of the SpnHL-Vcpal complex and confirmed the hypothesis that additional hydrophobic interactions with Phe-343, His-399, and Thr-400 in the active site led to increased inhibition. A homology structural model of BTH was also generated to suggest binding modes of Vcpal to this hyaluronidase. The long alkyl chain seemed to interact with an extended, hydrophobic channel formed by mostly conserved amino acids Ala-84, Leu-91, Tyr-93, Tyr-220, and Leu-344 in BTH.

Received for publication, June 2, 2004 , and in revised form, August 9, 2004.

The atomic coordinates and structure factors (code 1W3Y) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

^* This work was supported in part by National Institutes of Health Grant AI44079 (to M. J. J.) and by the Studienstiftung des Deutschen Volkes (to A. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence may be addressed: Children's Hospital Oakland Research Inst., 5700 Martin Luther King, Jr. Way, Oakland, CA 94609. Tel.: 510-450-7932; Fax: 510-450-7914; E-mail: mjedrzejas{at}chori.org. ^** To whom correspondence may be addressed. Tel.: 49-941-9434827; Fax: 49-941-9434820; E-mail: armin.buschauer{at}chemie.uniregensburg.de.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Zhang, A. G. Bharadwaj, A. Casper, J. Barkley, J. J. Barycki, and M. A. Simpson Hyaluronidase Activity of Human Hyal1 Requires Active Site Acidic and Tyrosine Residues J. Biol. Chem., April 3, 2009; 284(14): 9433 - 9442. [Abstract] [Full Text] [PDF]

				G. Yadav, R. L. A. Prasad, B. K. Jha, V. Rai, V. Bhakuni, and K. Datta Evidence for Inhibitory Interaction of Hyaluronan-binding Protein 1 (HABP1/p32/gC1qR) with Streptococcus pneumoniae Hyaluronidase J. Biol. Chem., February 6, 2009; 284(6): 3897 - 3905. [Abstract] [Full Text] [PDF]

				E. S.A. Hofinger, M. Spickenreither, J. Oschmann, G. Bernhardt, R. Rudolph, and A. Buschauer Recombinant human hyaluronidase Hyal-1: insect cells versus Escherichia coli as expression system and identification of low molecular weight inhibitors Glycobiology, April 1, 2007; 17(4): 444 - 453. [Abstract] [Full Text] [PDF]

				H. Harada and M. Takahashi CD44-dependent Intracellular and Extracellular Catabolism of Hyaluronic Acid by Hyaluronidase-1 and -2 J. Biol. Chem., February 23, 2007; 282(8): 5597 - 5607. [Abstract] [Full Text] [PDF]

				D. J. Rigden, A. Botzki, M. Nukui, R. B. Mewbourne, E. Lamani, S. Braun, E. von Angerer, G. Bernhardt, S. Dove, A. Buschauer, et al. Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: structure of a complex with a 2-phenylindole Glycobiology, August 1, 2006; 16(8): 757 - 765. [Abstract] [Full Text] [PDF]

				T. Isoyama, D. Thwaites, M. G. Selzer, R. I. Carey, R. Barbucci, and V. B. Lokeshwar Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases Glycobiology, January 1, 2006; 16(1): 11 - 21. [Abstract] [Full Text] [PDF]

				G. Garau, D. Lemaire, T. Vernet, O. Dideberg, and A. M. Di Guilmi Crystal Structure of Phosphorylcholine Esterase Domain of the Virulence Factor Choline-binding Protein E from Streptococcus pneumoniae: NEW STRUCTURAL FEATURES AMONG THE METALLO-{beta}-LACTAMASE SUPERFAMILY J. Biol. Chem., August 5, 2005; 280(31): 28591 - 28600. [Abstract] [Full Text] [PDF]